|
Nobuhisa Hagiwara
Department Other, Other Position |
|
| Article types | Original article |
| Language | English |
| Peer review | Peer reviewed |
| Title | Baseline serum sitosterol level as predictor of adverse clinical events in acute coronary syndrome patients with dyslipidaemia: A sub-analysis of HIJ-PROPER. |
| Journal | Formal name：Atherosclerosis Abbreviation：Atherosclerosis ISSN code：0021-9150/1879-1484 |
| Domestic / Foregin | Foregin |
| Publisher | Elsevier B.V. |
| Volume, Issue, Page | 274,pp.139-145 |
| Author and coauthor | YAMAGUCHI Junichi†*, KAWADA-WATANABE Erisa, KOYANAGI Ryo, ARASHI Hiroyuki, SEKIGUCHI Haruki, NAKAO Koichi, TOBARU Tetsuya, TANAKA Hiroyuki, OKA Toshiaki, ENDO Yasuhiro, SAITO Katsumi, UCHIDA Tatsuro, MATSUI Kunihiko, OGAWA Hiroshi, HAGIWARA Nobuhisa |
| Authorship | Last author |
| Publication date | 2018/07 |
| Summary | CONCLUSIONS:
Aggressive lipid-lowering treatment with ezetimibe had a positive effect on clinical outcomes in the high sitosterol subset of ACS patients with dyslipidaemia, but not in the low sitosterol subset. This effect was independent of LDL-C reduction and suggests that sitosterol measurement on admission in ACS patients might contribute to a "personalised" lipid-lowering approach. |
| DOI | 10.1016/j.atherosclerosis.2018.04.036 |
| PMID | 29772482 |